Choose a Topic
News
View the latest transplant news and stories.
MINNEAPOLIS, MINN., May 24, 2023 – Results from a joint study between CIBMTR® (Center for International Blood and Marrow Transplant Research®)—a research collaboration between the National Marrow Donor Program® (NMDP)/Be The Match® and the Medical College of Wisconsin (MCW)—and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) defining COVID-19 vaccine response in allogeneic hematopoietic cell transplantation (HCT) were recently published in eClinicalMedicine.
Results of Pre-MEASURE Study By NMDP/Be The Match, CIBMTR, and the NHLBI Published in JAMA
The AcCELLerate Forum To Focus On Creating A Sustainable Ecosystem of Cell and Gene Therapy
National Marrow Donor Program/Be The Match Awards Amy Strelzer Manasevit Research Program Grant to Dan Peltier, MD, PhD
National Marrow Donor Program/Be The Match Announce Plan to Launch ACCESS Clinical Trial
BMT CTN research presented today at the 62nd ASH Annual Meeting & Exposition MINNEAPOLIS, MINN.—DEC. 5, 2020— Initial results from a recent study indicate that for patients between the ages of 50 and 75, overall survival nearly doubled when patients with myelodysplastic syndrome (MDS) re
NMDP/Be The Match announces the launch of Be The Match BioBank cryopreservation service
Service helps increase donor availability and add reliability to a patient’s transplant timeline
The National Marrow Donor Program ® (NMDP)/Be The Match ® today announced the appointment of Amy Ronneberg as Chief Executive Officer (CEO)—the first female CEO for the organization.